Leveljump Healthcare (TSXV:JUMP) Beneish M-Score: -2.56 (As of Jun. 26, 2026)

What is Leveljump Healthcare Beneish M-Score?

Leveljump Healthcare TSXV:JUMP Beneish M-Score is -2.56 as of Jun. 26, 2026. The stock has 2 warning signs investors should review. Among 195 Medical Diagnostics & Research companies, Leveljump Healthcare ranks worse than 54.36% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.56 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Leveljump Healthcare's Beneish M-Score or its related term are showing as below:

TSXV:JUMP' s Beneish M-Score Range Over the Past 10 Years
Min: -407.48 Med: -2.56 Max: 1.31
Current: -2.56

During the past 6 years, the highest Beneish M-Score of Leveljump Healthcare was 1.31. The lowest was -407.48. And the median was -2.56.

Leveljump Healthcare Beneish M-Score Related Terms

Leveljump Healthcare Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Leveljump Healthcare's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Leveljump Healthcare Beneish M-Score Chart

Leveljump Healthcare Annual Data

Trend

Aug19

Aug20

Dec21

Dec22

Dec23

Dec24

Beneish M-Score

Get a 7-Day Free Trial

0.00

-2.03

-3.08

-2.12

Leveljump Healthcare Quarterly Data
	Nov20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25
Beneish M-Score	Get a 7-Day Free Trial															-3.85	-2.12	-2.25	-2.56	-2.56

TSXV:JUMP vs TMO, DHR, IDXX: Beneish M-Score Comparison

For the Diagnostics & Research subindustry, Leveljump Healthcare's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Leveljump Healthcare Beneish M-Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Leveljump Healthcare's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Leveljump Healthcare's Beneish M-Score falls into.

Save Embed

Leveljump Healthcare Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Leveljump Healthcare for today is based on a combination of the following eight different indices:

-4.84

0.92 * DSRI

0.528 * GMI

0.404 * AQI

0.892 * SGI

0.115 * DEPI

-4.84

0.92 * 1.0161

0.528 * 0.8543

0.404 * 1.0477

0.892 * 1.1242

0.115 * 1.4552

0.172 * SGAI

4.679 * TATA

0.327 * LVGI

0.172 * 1.9205

4.679 * -0.016441

0.327 * 0.9037

-2.56

This Year (Sep25) TTM:

Last Year (Sep24) TTM:

Total Receivables was C$3.05 Mil.
Revenue was 4.836 + 4.692 + 4.581 + 4.802 = C$18.91 Mil.
Gross Profit was 0.938 + 0.964 + 1.092 + 0.9 = C$3.89 Mil.
Total Current Assets was C$3.31 Mil.
Total Assets was C$21.84 Mil.
Property, Plant and Equipment(Net PPE) was C$6.35 Mil.
Depreciation, Depletion and Amortization(DDA) was C$1.12 Mil.
Selling, General, & Admin. Expense(SGA) was C$3.14 Mil.
Total Current Liabilities was C$5.94 Mil.
Long-Term Debt & Capital Lease Obligation was C$7.07 Mil.
Net Income was -0.026 + -0.133 + 0.201 + 1.95 = C$1.99 Mil.
Non Operating Income was -0.044 + -0.005 + 0.222 + 0.103 = C$0.28 Mil.
Cash Flow from Operations was 0.41 + 0.829 + 0.573 + 0.263 = C$2.08 Mil.

Total Receivables was C$2.67 Mil.
Revenue was 4.449 + 4.42 + 4.058 + 3.895 = C$16.82 Mil.
Gross Profit was 0.877 + 0.774 + 0.641 + 0.667 = C$2.96 Mil.
Total Current Assets was C$2.87 Mil.
Total Assets was C$18.60 Mil.
Property, Plant and Equipment(Net PPE) was C$5.83 Mil.
Depreciation, Depletion and Amortization(DDA) was C$1.63 Mil.
Selling, General, & Admin. Expense(SGA) was C$1.45 Mil.
Total Current Liabilities was C$5.12 Mil.
Long-Term Debt & Capital Lease Obligation was C$7.15 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI	=	(Receivables_t / Revenue_t)	/	(Receivables_t-1 / Revenue_t-1)
	=	(3.05 / 18.911)	/	(2.67 / 16.822)
	=	0.161282	/	0.158721
	=	1.0161

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI	=	GrossMargin_t-1	/	GrossMargin_t
	=	(GrossProfit_t-1 / Revenue_t-1)	/	(GrossProfit_t / Revenue_t)
	=	(2.959 / 16.822)	/	(3.894 / 18.911)
	=	0.175901	/	0.205912
	=	0.8543

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI	=	(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t)	/	(1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
	=	(1 - (3.313 + 6.345) / 21.836)	/	(1 - (2.871 + 5.827) / 18.597)
	=	0.557703	/	0.53229
	=	1.0477

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI	=	Sales_t	/	Sales_t-1
	=	Revenue_t	/	Revenue_t-1
	=	18.911	/	16.822
	=	1.1242

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI	=	(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))	/	(Depreciation_t / (Depreciaton_t + PPE_t))
	=	(1.626 / (1.626 + 5.827))	/	(1.119 / (1.119 + 6.345))
	=	0.218167	/	0.14992
	=	1.4552

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI	=	(SGA_t / Sales_t)	/	(SGA_t-1 /Sales_t-1)
	=	(3.137 / 18.911)	/	(1.453 / 16.822)
	=	0.165882	/	0.086375
	=	1.9205

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI	=	((LTD_t + CurrentLiabilities_t) / TotalAssets_t)	/	((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
	=	((7.074 + 5.942) / 21.836)	/	((7.147 + 5.12) / 18.597)
	=	0.59608	/	0.659623
	=	0.9037

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA	=	(IncomefromContinuingOperations_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(NetIncome_t - NonOperatingIncome_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(1.992 - 0.276	-	2.075)	/	21.836
	=	-0.016441

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Leveljump Healthcare has a M-score of -2.56 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →

What does a Beneish M-Score of -2.56 mean?

Leveljump Healthcare (TSXV:JUMP) has a Beneish M-Score of -2.56 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Leveljump Healthcare and its competitors. According to the industry distribution chart, Leveljump Healthcare ranks #106 out of 195 companies in the Medical Diagnostics & Research industry, placing it in the top 54.4%.

Is Leveljump Healthcare's Beneish M-Score too high?

Leveljump Healthcare's current Beneish M-Score is -2.56. Based on the distribution chart, Leveljump Healthcare ranks #106 out of 195 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint.

How does Leveljump Healthcare's Beneish M-Score compare to TMO and DHR?

According to the Medical Diagnostics & Research industry distribution chart, Leveljump Healthcare ranks #106 out of 195 companies for Beneish M-Score. This places Leveljump Healthcare in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Beneish M-Score for a Medical Diagnostics & Research company?

A good Beneish M-Score depends on the Medical Diagnostics & Research industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Beneish M-Score mean?

A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Leveljump Healthcare and its competitors. Leveljump Healthcare's current Beneish M-Score is -2.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Leveljump Healthcare stock overvalued right now?

Based on GuruFocus' analysis, Leveljump Healthcare (TSXV:JUMP) is currently considered Modestly Undervalued. The stock's GF Value™ is C$0.07, compared to a current price of C$0.06 — trading 21.4% below its estimated fair value. The current Beneish M-Score is -2.56. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Beneish M-Score calculated?

Beneish M-Score is calculated from a company's financial statements. For Leveljump Healthcare (TSXV:JUMP), the current Beneish M-Score is -2.56 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Leveljump Healthcare Business Description

Industry Healthcare Medical Diagnostics & Research

Comparable Companies TSXV:AVCR TSXV:TELO TSXV:ARC TSXV:MBI.H XCNQ:IZO TMO DHR SHSE:603259 XSWX:LONN IDXX A WAT NTRA IQV ILMN MTD DGX LH GH MEDP

Address 52 Scarsdale Road, Suite 207, Toronto, ON, CAN, M3B 2R7

Website https://www.leveljumphealthcare.com

Leveljump Healthcare Corp is engaged in providing radiology services both by providing direct patient images and by providing Teleradiology services, which is the process of providing remote off-site reading of radiology scans such as CT, MRI, and X-ray. Its teleradiology services allow hospital staff to scan their emergency room patients, then page the company's radiologist on call, who can then remotely view, via a secured server, the images and diagnose the patient, and provide a report back to the hospital. Leveljump provides its direct-to-patient services at its Independent Healthcare Facilities (IHFs). The company operates as a single segment, with all of its core assets, intellectual property, and development work being conducted in Canada.